Welcome to our dedicated page for GALEXXY HLDGS news (Ticker: GXXY), a resource for investors and traders seeking the latest updates and insights on GALEXXY HLDGS stock.
Galexxy Holdings Inc. (OTC PINK: GXXY) is a diversified company with a focus on emerging markets. They have expanded their strategic commercial supply and lease agreements, marketing programs, and installations of smart kiosks. The company works closely with Delta 88 and uVending, aiming to generate substantial revenues in the coming years. Galexxy is known for its innovative geospatial advertising solutions and proprietary products, driving foot traffic and sales through VendGenie Smart Kiosks.
Recently, Galexxy has appointed Trent D'Ambrosio as the Vice President of Sales and Marketing. With a successful background in executive business management and sales, Trent is expected to drive rapid sales revenue growth and expand retail and wholesale sales programs. Galexxy is set to launch the Galexxy Sales App, integrating Verb and Hussle technologies, to empower sales leaders and scale sales organizations through advanced features like live streaming, training, and one-click sampling.
The company is redirecting its focus to the Functional Mushroom Market and direct-selling industry, anticipating substantial growth and positioning themselves as industry leaders. Galexxy is dedicated to revolutionizing the health and wellness sector with innovative products and technology-driven solutions, all aimed at maximizing shareholder value and ensuring long-term sustainability.
Funding Adaptin, a new venture in the wellness market, Galexxy Holdings aims to tap into the growing adaptogen market and provide innovative products with transparent compensation plans. With a visionary leadership team and a strategic approach, Adaptin is set to offer unique opportunities to health and wellness enthusiasts and brand advocates, driving innovation and growth in the direct sales landscape.
Adaptin, a new wellness brand, announced its launch on June 25, 2024, aiming to bring functional adaptogens and nootropics to a global audience through innovative marketing strategies. The US adaptogen and functional mushroom supplements market was valued at $40 billion in 2023, part of the $5.7 trillion global wellness market. The brand offers products like natural and organic gummies and elixirs designed to combat anxiety, stress, lack of sleep, and focus issues. Adaptin's proprietary 100-day extraction process ensures high-quality blends. The company plans a preview in Q3 2024 and a full launch in October 2024, with opportunities for early access and profit-sharing.
Galexxy Holdings (OTC PINK:GXXY) has elected Tyler Whitehead to its board of directors. Whitehead is the co-founder and CEO of Adaptin, former CEO of Arbonne, and was President for Nu Skin Enterprises. Over 20 years, he has driven growth in the wellness sector, with experience in global markets, innovation, and legal and risk management. His recent role at Arbonne involved transforming the brand through digital and sustainable business models. Whitehead aims to leverage his expertise to expand Galexxy's reach in the $4.6 trillion global wellness market.
Galexxy Holdings Inc. announces the creation of a new company, Adaptin, , focusing on the functional mushroom and adaptogen market. Adaptin aims to tap into the rapidly growing $32B global market by offering innovative products and business models. Tyler Whitehead is appointed as CEO and Co-Founder, with Galexxy maintaining a 56.5% ownership stake. The partnership aims to drive innovation, expand globally, and enhance customer engagement.
FAQ
What is the current stock price of GALEXXY HLDGS (GXXY)?
What is the market cap of GALEXXY HLDGS (GXXY)?
Who is Trent D'Ambrosio and what role does he play at Galexxy Holdings?
What is the Galexxy Sales App and how does it benefit sales leaders?
How is Galexxy Holdings repositioning its focus in the market?
What is Adaptin, and how does it contribute to Galexxy Holdings' growth strategy?